# Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

> **NCT07172204** · PHASE2 · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 25 (estimated)

## Conditions studied

- Intensive Chemotherapy Unfit
- Newly Diagnosed Acute Myeloid Leukemia (AML)
- Age ≥60

## Interventions

- **DRUG:** Alternately treated with VA/low CHA regimen

## Key facts

- **NCT ID:** NCT07172204
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2027-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07172204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07172204, "Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07172204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*